Andrew R. Vaillant, Ph.D., is Vice President, Operations and Chief Scientific Officer. He was one of the original discoverer of REPLICor’s antiviral technology. He directs all technology assessment and research and development activities at REPLICor. He is also responsible for all internal and outsourced scientific, manufacturing, regulatory and intellectual property activities and has an active role in the design, conduct and oversight of clinical trials. He previously held positions in two biotechnology companies. He was a postdoctoral fellow at the Montreal Neurological Institute and holds a Ph.D. in Cell Biology and a B.Sc. in Biology (Summa Cum Laude) from the University of Ottawa.